首页> 外文会议> >Isothermal And Non-Isothermal Crystallization Kinetics Of Amorphous Ketoconazole
【24h】

Isothermal And Non-Isothermal Crystallization Kinetics Of Amorphous Ketoconazole

机译:非晶态酮康唑的等温和非等温结晶动力学

获取原文

摘要

Amorphous pharmaceuticals are of manifold importance owing to their increased dissolution propertiesand greater bioavailability. Ketoconazole is an oral and topical antifungal drug which has moderate oralabsorption in the crystalline phase. Crystalline ketoconazole is sparingly soluble drug thus limiting itsdissolution properties. Amorphous ketoconazole if suitably formulated can be used with enhancedtherapeutic efficacy. An extensive study on the crystallization kinetics of conversion of amorphousketoconazole to crystalline form is done. In this study the non-isothermal kinetics of recrystallization ofamorphous ketoconazole was investigated using Differential Scanning Calorimetric Technique. Theamorphous phase was confirmed by PXRD studies. It was found that varying the amount of ketoconazoleseed crystals didn't affect the activation energy of amorphous ketoconazole to change from amorphous tothe crystalline phase. The value of activation energy was also found to be very high in the isothermalstudy emphasizing that ketoconazole amorphous is a stable glass. The glass stability value (Kgl) wasdetermined to range from 2-3 for amorphous ketoconazole. The stability of the glass decreased withincrease in the amount of seed crystals. The Avrami exponent values for amorphous ketoconazoledetermined by the non-isothermal studies corroborated that a one-dimensional linear crystallizationoccurred when amorphous ketoconazole transformed to the crystalline phase.
机译:由于其溶解性增加,无定形药物具有歧管重要性 更大的生物利用度。酮康唑是一种口腔和局部抗真菌药物,具有中度口服 在结晶相中吸收。结晶酮康唑略微可溶的药物,从而限制其 溶解特性。非晶酮康唑,如果适当配制,可用于增强 治疗效果。无定形转化率结晶动力学的广泛研究 进行酮康唑来完成结晶形式。在这项研究中,重结晶的非等温动力学 使用差示扫描量热技术研究了非晶酮康唑。这 通过PXRD研究证实了非晶相。发现改变酮康唑的量 种子晶体并不影响无定形酮康唑的活化能量,从非晶态变化 结晶相。活化能量的值也被发现在等温中非常高 研究强调酮康唑无定形是稳定的玻璃。玻璃稳定值(KGL)是 确定为无定形酮康唑的2-3。玻璃的稳定性减少了 增加种子晶体量。无定形酮康唑的Avrami指数值 由非等温研究确定的,证实了一维线性结晶 当Amorphous酮康唑转化为结晶相时发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号